Ozempic Shortage 2024: Current Status, Causes & Alternatives

For two years, the Ozempic shortage left millions of Type 2 diabetes patients struggling to fill their prescriptions—a public health crisis driven by unprecedented demand, viral social media attention, and manufacturing constraints. Here's where things stand in 2024 and what to do if you're still having trouble finding your medication.

Current Shortage Status (2024)

The FDA Drug Shortages Database—the official source for shortage designations—has removed several Ozempic dose strengths from active shortage status. As of mid-2024, the 0.5 mg and 1 mg doses have been more reliably available, while some regions and pharmacies may still experience intermittent supply gaps. The 2 mg dose has also improved in availability.

Wegovy (higher-dose semaglutide for weight management) has had its own parallel shortage that is also improving, with 0.25 mg, 0.5 mg, and 1 mg doses more readily available and higher doses still sometimes constrained.

Always verify current status at the FDA Drug Shortages Database (accessdata.fda.gov) or by calling your pharmacy directly.

Why Did the Ozempic Shortage Happen?

The semaglutide shortage was caused by the perfect storm of several factors:

1. Viral weight-loss coverage. Starting in late 2022, Ozempic became a household name after coverage in news media and social platforms highlighted dramatic weight-loss results. Prescriptions surged far beyond the diabetic patient population.
2. Off-label prescribing volume. Physicians began prescribing Ozempic for obesity at scale, years before Wegovy supply could meet demand.
3. Manufacturing constraints. Novo Nordisk's production capacity—designed around diabetic patient demand—could not scale fast enough. The proprietary peptide synthesis required to make semaglutide is technically complex and slow to expand.
4. FDA fill-finish bottlenecks. Sterile injectable manufacturing requires specialized facilities; contracting additional manufacturers takes years.

Novo Nordisk's Response

Novo Nordisk has committed over $6 billion in manufacturing capacity expansion since 2023, including new fill-finish lines in Denmark and expanded API production. The company prioritized diabetes patients in allocation during the peak shortage and has been gradually releasing more supply to the market throughout 2024.

What To Do If You Can't Find Ozempic

1. Call Multiple Pharmacies

Availability varies dramatically by pharmacy and location. Independent pharmacies and smaller chains sometimes have stock when major retailers don't. Call ahead before driving— pharmacies cannot hold stock without a prescription, but they can tell you whether they have current inventory.

2. Ask Your Doctor About Dose Flexibility

If your target dose is unavailable, your physician may be able to temporarily prescribe an available dose (e.g., stay on 0.5 mg if 1 mg is out of stock) while you wait for restocking.

3. Consider Alternative GLP-1 Medications

Several GLP-1 receptor agonists are approved for Type 2 diabetes and may be available when Ozempic is not:

• Rybelsus (oral semaglutide) — Same active ingredient as Ozempic in pill form; generally less affected by the injectable shortage.
• Trulicity (dulaglutide) — Weekly injection; different mechanism but similar GLP-1 class.
• Mounjaro / Zepbound (tirzepatide) — Dual GIP/GLP-1 agonist from Eli Lilly; highly effective and supply has been improving.
• Victoza (liraglutide, daily injection) — Older GLP-1 drug, may be more readily available.

4. Compounded Semaglutide

During FDA shortage designations, licensed 503B outsourcing facilities could legally produce compounded semaglutide. As shortage status changes, the legality of compounding specific dose strengths changes as well. Before pursuing compounded semaglutide, confirm:

• The current FDA shortage status for your specific dose
• That the compounding pharmacy is a licensed 503A or 503B facility
• That your physician supports this approach

The FDA has issued warnings about unlicensed compounders selling substandard or inaccurately dosed semaglutide—source only from accredited facilities.

5. GoodRx and Out-of-Pocket Options

Some patients find Ozempic at smaller regional pharmacies that accept GoodRx pricing. Searching GoodRx by zip code can reveal which local pharmacies have the medication available and at what price.

Looking Ahead: Will the Shortage Return?

Analysts expect semaglutide supply to continue improving through 2025 and beyond as Novo Nordisk's expanded capacity comes online. However, if demand continues to grow with new approvals (cardiovascular risk reduction, sleep apnea, etc.), supply tightness may recur. Keeping a 1–2 month buffer supply (if your insurer allows early refills) is a prudent strategy when you have access.

Frequently Asked Questions

Shortage status information is subject to rapid change. Always verify current availability with the FDA Drug Shortages Database and your pharmacist. This page is for informational purposes only.